Published in Blood Weekly, April 3rd, 1995
At the meeting of its board of directors February 2-4, 1995, AABB voted not to change its Standard B2.650, which provides for the indefinite deferral of potential donors who have had a diagnosis of malaria. The standard is more conservative than a standard approved July 26, 1994 by the U.S. Food and Drug Administration (FDA). The FDA standard mandated a three-year deferral for asymptomatic persons who previously had been diagnosed with malaria.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.